Back
Vertex Pharmaceuticals Stock Predictions
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
44
VRTX
Vertex Pharmaceuticals
Last Price:
$438.72
Seasonality Move:
7.54%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Vertex Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 23.1% based on the past 33 years of stock performance.
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Vertex Pharmaceuticals Stock Undervalued?The current Vertex Pharmaceuticals [VRTX] share price is $438.65. The Score for VRTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 23.1% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Sell
44
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals overpriced?
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
519.88
52-Week Low:
377.85
Prediction Charts
Market Cap:
112.6B
Price in USD:
438.65
Volume:
1.5M
Beta:
0.95
Technical Analysis
SMA50:
483.34
SMA100:
463.03
SMA200:
468.95
52-Wk Change:
-0.45%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?Yes, Vertex Pharmaceuticals is a publicly traded company.
-
What is the Vertex Pharmaceuticals stock quote today?The Vertex Pharmaceuticals stock price is 438.65 USD today.
-
How to buy Vertex Pharmaceuticals stock online?You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-29 | 494.26 | 503.50 | 506.96 | 490.85 |
| Apr-30 | 500.79 | 509.50 | 510.77 | 497.34 |
| May-1 | 507.00 | 498.86 | 507.75 | 498.21 |
| May-2 | 505.86 | 501.15 | 509.00 | 498.03 |
| May-5 | 501.45 | 500.19 | 505.61 | 498.02 |
| May-6 | 465.56 | 450.03 | 467.85 | 428.55 |
| May-7 | 447.52 | 434.82 | 449.00 | 432.29 |
| May-8 | 430.17 | 429.60 | 432.14 | 423.40 |
| May-9 | 430.22 | 424.99 | 434.93 | 424.80 |
| May-12 | 425.30 | 439.37 | 441.10 | 423.20 |
| May-13 | 437.53 | 432.00 | 442.12 | 429.54 |
| May-14 | 432.00 | 421.16 | 433.41 | 416.60 |
| May-15 | 424.69 | 434.38 | 434.42 | 421.76 |
| May-16 | 435.30 | 438.65 | 438.95 | 429.94 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.39 per share, an increase this year of $17.52 per share, and an increase next year of $2.66 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.